Jeffrey W Sherman Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

Jeffrey W Sherman is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 219,188 shares of XERS, which is worth approximately $2.03 Million. The most recent transaction as insider was on Aug 28, 2025, when has been sold 42,232 shares (Common Stock) at a price of $7.92 per share, resulting in proceeds of $334,477. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 219K

2.24% 3M change

33.34% 12M change

Total Value Held $2.03 Million

JEFFREY W SHERMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 28 2025	SELL Open market or private sale	$334,477 $7.92 p/Share	42,232 Reduced 16.15%	219,188 Common Stock
Aug 28 2025	BUY Exercise of conversion of derivative security	$313,286 $6.66 p/Share	47,040 Added 15.25%	261,420 Common Stock
Jun 04 2025	BUY Grant, award, or other acquisition	-	50,000 Added 18.91%	214,380 Common Stock
Jun 05 2024	BUY Grant, award, or other acquisition	-	50,000 Added 23.32%	164,380 Common Stock
Mar 15 2024	BUY Other acquisition or disposition	-	6,502 Added 5.38%	114,380 Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	-	42,500 Added 28.26%	107,878 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	-	15,000 Added 18.66%	65,378 Common Stock
Oct 05 2021	BUY Grant, award, or other acquisition	-	50,378 Added 50.0%	50,378 Common Stock

Also insider at

HZNP

Horizon Therapeutics Public Ltd Co Healthcare

EVP and Chief Medical Officer

SBBP

Strongbridge Biopharma plc

Director

XERS

XERIS PHARMACEUTICALS INC Healthcare

Director

LRMR

Larimar Therapeutics, Inc. Healthcare

Director

JWS